Limited coverage drugs – alendronate
Special Authority requests can now be submitted online. It's simple and quick!
Learn more or log in.
|
Generic name |
alendronate, including in combination with cholecalciferol (vitamin D3) |
|---|---|
|
Strength |
10 mg, 70 mg, 70 mg/5600 IU |
|
Form |
tablet |
|
Special Authority criteria |
Approval period |
|---|---|
|
Clinical or radiographically documented fracture due to osteoporosis. OR Glucocorticoid-induced osteoporosis in patients who are receiving or expected to receive the equivalent dose of 7.5 mg of prednisone per day or greater AND for 90 consecutive days or longer. |
Indefinite
1 year |
Practitioner exemptions
- None
Special notes
- Patients who meet the above criteria for osteoporosis for alendronate automatically receive coverage for both alendronate and risedronate
- Clinical fracture is defined as a symptomatic (painful) fracture
- Radiographically documented fracture is defined as a fracture identified by x-ray (e.g., vertebral compression fracture). This may be asymptomatic
- Coverage is intended for patients taking glucocorticoids with significant systemic absorption only (e.g., by oral or parenteral routes)
